Your browser doesn't support javascript.
loading
Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease.
Shu, Liming; Vivekanandan-Giri, Anuradha; Pennathur, Subramaniam; Smid, Bouwien E; Aerts, Johannes M F G; Hollak, Carla E M; Shayman, James A.
Afiliación
  • Shu L; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Vivekanandan-Giri A; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Pennathur S; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Smid BE; Department of Endocrinology and Metabolism, Academic Medical Centre, Amsterdam, The Netherlands.
  • Aerts JM; Department of Medical Biochemistry, Academic Medical Centre, Amsterdam, The Netherlands.
  • Hollak CE; Department of Endocrinology and Metabolism, Academic Medical Centre, Amsterdam, The Netherlands.
  • Shayman JA; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Kidney Int ; 86(1): 58-66, 2014 Jul.
Article en En | MEDLINE | ID: mdl-24402087

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tirosina / Enfermedades Vasculares / Enfermedad de Fabry Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Animals / Humans / Male / Middle aged Idioma: En Revista: Kidney Int Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tirosina / Enfermedades Vasculares / Enfermedad de Fabry Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Animals / Humans / Male / Middle aged Idioma: En Revista: Kidney Int Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos